These Analysts Revise Their Forecasts On Wix.com Following Q2 Results

Wix.com (WIX) reported stronger-than-expected Q2 results, with adjusted EPS of $2.28 and revenue of $489.93 million, both surpassing analyst estimates, and revenue growing 12% year-over-year. The company also slightly raised its fiscal 2025 revenue and bookings outlook, leading to a 6.5% gain in its shares. However, despite the positive performance and increased guidance, several prominent analysts, including Needham, Raymond James, Barclays, and UBS, lowered their price targets, suggesting a recalibration of long-term growth or valuation expectations, while Scotiabank notably raised its target.

Analysis

Wix.com (WIX) delivered a robust second quarter, exceeding analyst expectations on both top and bottom lines. Revenue grew 12% year-over-year to $489.93 million, surpassing consensus by approximately $2.5 million, while adjusted EPS of $2.28 significantly beat the estimated $1.74. Management attributes this performance to strong momentum in the core business, driven by new cohort outperformance, and expansion into a new total addressable market (TAM) through the Base44 acquisition. This operational strength prompted a modest increase in the full-year 2025 guidance for revenue and a more notable raise for bookings. However, the third-quarter revenue forecast of $498.00 million to $504.00 million places the midpoint slightly below the consensus of $502.33 million. Despite the immediate 6.5% share price increase, a significant divergence in analyst sentiment is apparent. While most analysts maintained positive ratings such as Buy or Overweight, four out of the five cited firms—including Needham, Raymond James, and UBS—lowered their price targets. This widespread reduction, even with positive ratings, suggests a recalibration of long-term valuation or growth expectations, possibly influenced by the softer Q3 outlook, even as near-term results remain strong.

Key Decisions for Investors

• Investors should weigh the company's demonstrated operational strength, reflected in the Q2 earnings beat and raised full-year bookings guidance, against the cautionary signal of multiple analysts lowering long-term price targets.
• Monitor Q3 revenue performance closely, as the guidance midpoint falling slightly below consensus may be a key driver for the analyst revisions and a potential indicator of near-term growth deceleration.
• It may be prudent to investigate the rationale behind the price target reductions, as the divergence between strong current results and lowered future valuations could signal concerns about macroeconomic sensitivity, competitive pressures, or long-term margin potential not immediately apparent in the earnings release.